Essa Pharmaceuticals | ApexOnco - Clinical Trials news and analysis

x

“Top quality, fast and so easy to use”

Andrea Gnirke-Maier

Director New Product Planning

Morphosys

Click here for more information

Deals

15 July 2025

Essa succumbs to Xoma

Trial results

16 April 2025

Mural hits a wall

The company scraps nemvaleukin after the latest failure, of Artistry-6.

Trial results

1 November 2024

Essa terminates an N-terminal journey

After beating "historical" Xtandi masofaniten fails to beat actual Xtandi.

Subscribe to Essa Pharmaceuticals